CPH 0.00% 0.9¢ creso pharma limited

Ann: Halucenex Secures Additional Pharmaceutical Grade Psilocybin, page-78

  1. 689 Posts.
    lightbulb Created with Sketch. 112
    Investors need to understand that this allows Creso to expedite trials.




    https://finfeed.com/small-caps/biotech/cph-further-derisks-acquisition-halucenex-adds-its-psychedelics-supply/

    "The additional grammage takes Halucenex’s total inventory to 22.3 grams, giving it a generous runway to progress and expedite clinical trial and R&D initiatives."

    Think of it as need X number of people for the trials but you ended up getting 2x.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.